Renovos Biologics
PrivateLast Round
Series A
Nov 20, 2023
Total Funding Raised
$1.12M
Company Overview
Renovos Biologics operates in Healthcare & Life Sciences and is based in Southampton. Its latest recorded funding round was a Series A round in November 2023.
Renovos Biologics is a biotechnology company that develops synthetic nanoclay gel platforms for regenerative medicine and therapeutic delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renovos Biologics Comparables
Compare Renovos Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Locate Bio | 78% | |
| Genera Research Ltd. | 78% | |
| Molecular Matrix, Inc. | 73% |
For institutional investors. Book with your work email.
Renovos Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 20, 2023 | ||||
| Grant | Feb 23, 2022 | ||||
| Seed | Feb 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Renovos Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| HS. | Seed |
| Henley Business Angels | Series A |
| Orthopaedic Research UK | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 183% MoM, from 447 to 1.3K.
- Nov 8, 2025
Monthly visitors grew 90% MoM.
For institutional investors. Book with your work email.
Renovos Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renovos Biologics's valuation, stock price, and market status.
Is Renovos Biologics a public or private company?
Renovos Biologics is a private company.
What is the current stock price of Renovos Biologics?
Renovos Biologics is a private company, so its shares have no public market price. Caplight tracks Renovos Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renovos Biologics worth (valuation)?
Valuation information for Renovos Biologics is not publicly available.
Can I buy Renovos Biologics stock?
Renovos Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renovos Biologics's last funding round?
Renovos Biologics's most recent funding round was Series A on November 20, 2023.
Who are the main investors in Renovos Biologics?
Key investors in Renovos Biologics include Innovate UK, HS., Henley Business Angels, Orthopaedic Research UK.
Will Renovos Biologics IPO soon?
No public IPO plans have been announced for Renovos Biologics.
How can I track Renovos Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Renovos Biologics's shares on secondary markets.